Create account

Coverage dated December 16, 2021 to December 19, 2021

European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

Headline from WFMZ Allentown

Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine authorized for use in EuropeNovavax and the European Commission previously announced an advance purchase agreement for up to 200

WFMZ Allentown's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

22 articles, oldest first.

  1. MedicalXpress

    WHO approves Novavax vaccine for emergency use against COVID (opens MedicalXpress)

    Published

    MedicalXpress's feed description

    The World Health Organization has given emergency approval to a coronavirus vaccine made by U.S.-based Novavax and the Serum Institute of India, paving the way for its inclusion in the U.N.-backed program to get such vaccines to poorer countries around the world.

  2. WFMZ Allentown

    European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine (opens WFMZ Allentown)

    Published

    WFMZ Allentown's feed description

    Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine authorized for use in EuropeNovavax and the European Commission previously announced an advance purchase agreement for up to 200

  3. France 24

    EU medical regulator backs Novavax as bloc's fifth vaccine against Covid-19 (opens France 24)

    Published

    France 24's feed description

    Get the latest Breaking News Alerts from France 24 in real time on Facebook and Twitter: @BreakingF24

  4. Forbes

    Novavax Covid-19 Vaccine Wins Authorization From European Union Regulator (opens Forbes)

    Published

    Forbes's feed description

    If confirmed by the EU’s executive commission, the Novavax shot will become the fifth option for Europeans looking to get the jab.

  5. Minneapolis Star Tribune

    EU approves 5th COVID-19 vaccine for bloc, one by Novavax (opens Minneapolis Star Tribune)

    Published

    Minneapolis Star Tribune's feed description

    The European Union's drugs regulator gave the green light Monday to a fifth COVID-19 vaccine for use in the 27-nation bloc, granting conditional marketing authorization to the two-dose vaccine made by U.S. biotech company Novavax.

  6. New York Times

    Novavax’s Covid Vaccine Is Authorized in Europe (opens New York Times)

    Published

    New York Times's feed description

    The vaccine will be the fifth to become available in the E.U., which already has ample supplies.

  7. Portland Press Herald

    EU approves 5th COVID-19 vaccine, one by Novavax (opens Portland Press Herald)

    Published

    Portland Press Herald's feed description

    The two-dose shot joins those from Pfizer, Moderna, Johnson & Johnson and AstraZeneca as authorized in the bloc.

  8. MedicalXpress

    EU watchdog approves Novavax COVID jab (opens MedicalXpress)

    Published

    MedicalXpress's feed description

    Europe's medicines watchdog on Monday approved a COVID jab by US-based Novavax, which uses a more conventional technology that the biotech firm hopes will reduce vaccine hesitancy.

  9. France 24

    EU set to back Novavax Covid vaccine (opens France 24)

    Published

    France 24's feed description

    The EU's drug regulator will decide Monday whether to approve a Covid jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy.

  10. Deutsche Welle

    COVID-19: Novavax gets European approval | DW (opens Deutsche Welle)

    Published

    Deutsche Welle's feed description

    Several months behind schedule, the Novavax protein subunit vaccine has been approved for use in Europe. This is potentially very important news for the fight against COVID-19. Why?

  11. Deutsche Welle

    COVID: EU regulators recommend approval of Novavax vaccine | DW (opens Deutsche Welle)

    Published

    Deutsche Welle's feed description

    The European Union’s drugs regulator have cleared the way for the protein-based vaccine, which would be the fifth shot authorized for the bloc.

  12. Deutsche Welle

    COVID: EU regulators to approve Novavax vaccine | DW (opens Deutsche Welle)

    Published

    Deutsche Welle's feed description

    The European Union’s drugs regulator is expected to approve a protein-based vaccine which would be the fifth shot authorized for the bloc.

  13. Washington Times

    EU approves 5th COVID-19 vaccine for bloc, one by Novavax, a Maryland company (opens Washington Times)

    Published

    Washington Times's feed description

    The European Union’s drugs regulator gave the green light Monday to a fifth COVID-19 vaccine for use in the 27-nation bloc, granting conditional marketing authorization to the two-dose vaccine made by U.S. biotech company Novavax.

  14. Al Jazeera

    EU approves Novavax shot as fifth COVID vaccine (opens Al Jazeera)

    Published

    Al Jazeera's feed description

    The European Medicines Agency paves the way for a fifth authorised COVID jab in the bloc, approving its use in adults.

  15. The Hill

    EU approves Novavax COVID-19 vaccine (opens The Hill)

    Published

    The Hill's feed description

    A European Union agency on Monday granted conditional authorization for the COVID-19 vaccine made by Novavax, making it the fifth coronavirus vaccine to be authorized for use in the EU.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine | Since Then